Evidence map›Paper›PMID 36092736›Full record

ArticleFrontiers in cell and developmental biology2022

Corrigendum: SNORA72 activates the Notch1/c-Myc pathway to promote stemness transformation of ovarian cancer cells.

Liwen Zhang, Rong Ma, Mengcong Gao, Yanyun Zhao, Xuemei Lv, Wenjing Zhu, Li Han, Panpan Su, Yue Fan, Yuanyuan Yan and 4 more

Open access · goldAbstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in cell and developmental biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 91% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 1 institution in 1 country.

Liwen ZhangDepartment of Pharmacology, School of Pharmacy, China Medical University, Shenyang, China.
Rong MaDepartment of Pharmacology, School of Pharmacy, China Medical University, Shenyang, China.
Mengcong GaoDepartment of Pharmacology, School of Pharmacy, China Medical University, Shenyang, China.
Yanyun ZhaoDepartment of Pharmacology, School of Pharmacy, China Medical University, Shenyang, China.
Xuemei LvDepartment of Pharmacology, School of Pharmacy, China Medical University, Shenyang, China.
Wenjing ZhuDepartment of Pharmacology, School of Pharmacy, China Medical University, Shenyang, China.
Li HanDepartment of Pharmacology, School of Pharmacy, China Medical University, Shenyang, China.
Panpan SuDepartment of Pharmacology, School of Pharmacy, China Medical University, Shenyang, China.
Yue FanDepartment of Pharmacology, School of Pharmacy, China Medical University, Shenyang, China.
Yuanyuan YanDepartment of Pharmacology, School of Pharmacy, China Medical University, Shenyang, China.
Lin ZhaoDepartment of Pharmacology, School of Pharmacy, China Medical University, Shenyang, China.
Heyao MaDepartment of Pharmacology, School of Pharmacy, China Medical University, Shenyang, China.
Minjie WeiDepartment of Pharmacology, School of Pharmacy, China Medical University, Shenyang, China.
Miao HeDepartment of Pharmacology, School of Pharmacy, China Medical University, Shenyang, China.
China Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article DOI: 10.3389/fcell.2020.583087.].

Indexed as

c-MycNotch1ovarian cancer stem cells (OCSCs)SNORA72stemness

Identifiers

PMID36092736
PMCPMC9462444
OpenAlexW4293162554

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.